| |
|
|
|
Kaleido Biosciences Inc.  
|
|
7.62 0.02 (0%) |
07-02 10:53 |
|
Open: |
7.7 |
Pre close: |
7.6 |
Target:
|
9.87 
|
|
High: |
7.72 |
Low: |
7.56 |
Resistance:
|
8.45
9.87
|
|
Volume: |
11,493 |
Market Cap: |
274M |
Support:
|
7.11
6.28
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.35
|
MACD |
MACD(12,26):
|
0.14 |
|
MA(20): |
7.30 |
Signal(12,26,9): |
0.15  |
|
MA(100): |
6.59 |
Stochastic Oscillator |
%K(14,3):
|
60.24 |
|
MA(250): |
7.05 |
%D(3): |
51.98 |
|
Average Volume(K) |
3-Month: |
15222
|
52-Week |
High:
|
11.42 |
|
10-Days: |
16335 |
Low: |
2.82 |
|
RSI |
RSI(14):
|
59.59 |
Change(%): |
-31.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.850 |
Return on Equity (ttm) |
-121.7 |
Shares Out. (M) |
35.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-53.7 |
Shares Float (M) |
11.88 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.20 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
80.56 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1680 |
|
Book Value (p.s.) |
1.100 |
EBITDA (p.s.) |
-2.328 |
P/E |
-2.73 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.08 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-70.90 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-46.26 |
P/CF |
-3.95 |
|
|
|
|
|
|
